{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T07:15:23Z","timestamp":1795072523273,"version":"4.10.2"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The medial temporal lobe (MTL) is hypothesized to be relatively spared in early-onset Alzheimer\u2019s disease (EOAD). Yet, detailed examination of MTL subfields and drivers of atrophy in amnestic EOAD is lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      BioFINDER-2 participants with memory impairment, abnormal amyloid-\u03b2 and tau-PET were included. Forty-one amnestic EOAD individuals \u226465 years and, as comparison, late-onset AD (aLOAD, \u226570 years,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009154) and amyloid-\u03b2-negative cognitively unimpaired controls were included. MTL subregions and biomarkers of (co-)pathologies were measured.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>AD groups showed smaller MTL subregions compared to controls. Atrophy patterns were similar across AD groups: aLOAD showed thinner entorhinal cortices than aEOAD; aEOAD showed thinner parietal regions than aLOAD. aEOAD showed lower white matter hyperintensities than aLOAD. No differences in MTL tau-PET or transactive response DNA binding protein 43-proxy positivity were found.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found evidence for MTL atrophy in amnestic EOAD and overall similar levels to aLOAD of MTL tau pathology and co-pathologies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-024-01571-z","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T04:04:09Z","timestamp":1726459449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Anika","family":"Wuestefeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Pichet Binette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"van Westen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Strandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Stomrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Mattsson-Carlgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shorena","family":"Janelidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Palmqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Baumeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Berron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Yushkevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Spotorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.M.","family":"Wisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"issue":"1","key":"1571_CR1","first-page":"34","volume":"25","author":"MF Mendez","year":"2019","unstructured":"Mendez MF. Early-onset Alzheimer Disease and its variants. Contin Minneap Minn. 2019;25(1):34\u201351.","journal-title":"Contin Minneap Minn"},{"issue":"1","key":"1571_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/0891988706297086","volume":"20","author":"GA Marshall","year":"2007","unstructured":"Marshall GA, Fairbanks LA, Tekin S, Vinters HV, Cummings JL. Early-Onset Alzheimer\u2019s disease is Associated with Greater Pathologic Burden. J Geriatr Psychiatry Neurol. 2007;20(1):29\u201333.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"1571_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neurobiolaging.2017.02.010","volume":"54","author":"AL Aziz","year":"2017","unstructured":"Aziz AL, Giusiano B, Joubert S, Duprat L, Didic M, Gueriot C, et al. Difference in imaging biomarkers of neurodegeneration between early and late-onset amnestic Alzheimer\u2019s disease. Neurobiol Aging. 2017;54:22\u201330.","journal-title":"Neurobiol Aging"},{"key":"1571_CR4","doi-asserted-by":"publisher","unstructured":"Polsinelli AJ, Logan PE, Lane KA, Manchella MK, Nemes S, Sanjay AB et al. APOE \u03b54 carrier status and sex differentiate rates of cognitive decline in early- and late-onset Alzheimer\u2019s disease. Alzheimers Dement [Internet]. 2023 [cited 2023 Apr 24];n\/a(n\/a). https:\/\/doi.org\/10.1002\/alz.12831","DOI":"10.1002\/alz.12831"},{"issue":"7","key":"1571_CR5","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1093\/brain\/awab099","volume":"144","author":"S Spina","year":"2021","unstructured":"Spina S, La Joie R, Petersen C, Nolan AL, Cuevas D, Cosme C, et al. Comorbid neuropathological diagnoses in early versus late-onset Alzheimer\u2019s disease. Brain J Neurol. 2021;144(7):2186\u201398.","journal-title":"Brain J Neurol"},{"key":"1571_CR6","doi-asserted-by":"crossref","unstructured":"Tanner JA, Iaccarino L, Edwards L, Asken BM, Gorno-Tempini ML, Kramer JH et al. Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer\u2019s disease. Brain. 2022;awac229.","DOI":"10.1093\/brain\/awac229"},{"key":"1571_CR7","doi-asserted-by":"publisher","unstructured":"Hammers DB, Eloyan A, Taurone A, Thangarajah M, Beckett L, Gao S et al. Profiling baseline performance on the Longitudinal Early-Onset Alzheimer\u2019s Disease Study (LEADS) cohort near the midpoint of data collection. Alzheimers Dement [Internet]. 2023 May 31 [cited 2023 Sep 5];n\/a(n\/a). https:\/\/doi.org\/10.1002\/alz.13160","DOI":"10.1002\/alz.13160"},{"issue":"7","key":"1571_CR8","doi-asserted-by":"publisher","first-page":"e19219","DOI":"10.1016\/j.neurobiolaging.2013.01.004","volume":"34","author":"C H","year":"2013","unstructured":"H C, S J, SJ K, JM L, JH L, GH K, et al. Longitudinal changes of cortical thickness in early- versus late-onset Alzheimer\u2019s disease. Neurobiol Aging. 2013;34(7):e19219\u2013192115.","journal-title":"Neurobiol Aging"},{"issue":"11","key":"1571_CR9","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1016\/j.neurobiolaging.2015.04.019","volume":"36","author":"L Hamelin","year":"2015","unstructured":"Hamelin L, Bertoux M, Bottlaender M, Corne H, Lagarde J, Hahn V, et al. Sulcal morphology as a new imaging marker for the diagnosis of early onset Alzheimer\u2019s disease. Neurobiol Aging. 2015;36(11):2932\u20139.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1571_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3233\/JAD-142292","volume":"46","author":"R Migliaccio","year":"2015","unstructured":"Migliaccio R, Agosta F, Possin KL, Canu E, Filippi M, Rabinovici GD, et al. Mapping the progression of atrophy in early- and late-onset Alzheimer\u2019s Disease. J Alzheimers Dis JAD. 2015;46(2):351\u201364.","journal-title":"J Alzheimers Dis JAD"},{"issue":"5026","key":"1571_CR11","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1126\/science.1896849","volume":"253","author":"LR Squire","year":"1991","unstructured":"Squire LR, Zola-Morgan S. The medial temporal lobe memory system. Science. 1991;253(5026):1380\u20136.","journal-title":"Science"},{"issue":"3","key":"1571_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1017\/S0140525X00035391","volume":"17","author":"H Eichenbaum","year":"1994","unstructured":"Eichenbaum H, Otto T, Cohen NJ. Two functional components of the hippocampal memory system. Behav Brain Sci. 1994;17(3):449\u201372.","journal-title":"Behav Brain Sci"},{"key":"1571_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/bs.pbr.2015.04.001","volume":"219","author":"M Ritchey","year":"2015","unstructured":"Ritchey M, Libby LA, Ranganath C. Cortico-hippocampal systems involved in memory and cognition: the PMAT framework. Prog Brain Res. 2015;219:45\u201364.","journal-title":"Prog Brain Res"},{"issue":"4","key":"1571_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl). 1991;82(4):239\u201359.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"3","key":"1571_CR15","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3233\/JAD-215567","volume":"87","author":"J Llamas-Rodr\u00edguez","year":"2022","unstructured":"Llamas-Rodr\u00edguez J, Oltmer J, Greve DN, Williams E, Slepneva N, Wang R, et al. Entorhinal Subfield vulnerability to Neurofibrillary tangles in Aging and the preclinical stage of Alzheimer\u2019s Disease. J Alzheimers Dis. 2022;87(3):1379\u201399.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1571_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s40478-021-01225-3","volume":"9","author":"LEM Wisse","year":"2021","unstructured":"Wisse LEM, Ravikumar S, Ittyerah R, Lim S, Lane J, Bedard ML, et al. Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions. Acta Neuropathol Commun. 2021;9(1):128.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"1571_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC, Ch\u00e9telat G, Holtzman DM, Hyman BT, et al. Alzheimer disease. Nat Rev Dis Primer. 2021;7(1):33.","journal-title":"Nat Rev Dis Primer"},{"issue":"1","key":"1571_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.trci.2016.09.002","volume":"3","author":"GD Rabinovici","year":"2017","unstructured":"Rabinovici GD, Carrillo MC, Forman M, DeSanti S, Miller DS, Kozauer N, et al. Multiple comorbid neuropathologies in the setting of Alzheimer\u2019s disease neuropathology and implications for drug development. Alzheimers Dement Transl Res Clin Interv. 2017;3(1):83\u201391.","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"issue":"8","key":"1571_CR19","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/s41591-023-02450-0","volume":"29","author":"S Palmqvist","year":"2023","unstructured":"Palmqvist S, Rossi M, Hall S, Quadalti C, Mattsson-Carlgren N, Dellavalle S, et al. Cognitive effects of Lewy body pathology in clinically unimpaired individuals. Nat Med. 2023;29(8):1971\u20138.","journal-title":"Nat Med"},{"key":"1571_CR20","doi-asserted-by":"publisher","unstructured":"Tosun D, Yardibi O, Benzinger TLS, Kukull WA, Masters CL, Perrin RJ et al. Identifying individuals with non-Alzheimer\u2019s disease co-pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer\u2019s disease. Alzheimers Dement [Internet]. 2023 Sep 4 [cited 2023 Nov 1];n\/a(n\/a). https:\/\/doi.org\/10.1002\/alz.13447","DOI":"10.1002\/alz.13447"},{"issue":"2","key":"1571_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","volume":"134","author":"A Kapasi","year":"2017","unstructured":"Kapasi A, DeCarli C, Schneider JA. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol (Berl). 2017;134(2):171\u201386.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"6","key":"1571_CR22","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K, et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain. 2019;142(6):1503\u201327.","journal-title":"Brain"},{"issue":"8","key":"1571_CR23","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, Zetterberg H, Lopera F, Stomrud E, et al. Discriminative accuracy of plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative disorders. JAMA. 2020;324(8):772\u201381.","journal-title":"JAMA"},{"issue":"3","key":"1571_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JAD-2008-15312","volume":"15","author":"DJ Connor","year":"2008","unstructured":"Connor DJ, Sabbagh MN. Administration and Scoring Variance on the ADAS-Cog. J Alzheimers Dis. 2008;15(3):461\u20134.","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"1571_CR25","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","volume":"14","author":"O Hansson","year":"2018","unstructured":"Hansson O, Seibyl J, Stomrud E, Zetterberg H, Trojanowski JQ, Bittner T, et al. CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u03b2 PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimers Dement. 2018;14(11):1470\u201381.","journal-title":"Alzheimers Dement"},{"issue":"9","key":"1571_CR26","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/alz.12316","volume":"17","author":"O Hansson","year":"2021","unstructured":"Hansson O, Batrla R, Brix B, Carrillo MC, Corradini V, Edelmayer RM, et al. The Alzheimer\u2019s Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid \u03b2 and tau. Alzheimers Dement. 2021;17(9):1575\u201382.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1571_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13195-019-0517-9","volume":"11","author":"S Janelidze","year":"2019","unstructured":"Janelidze S, Stomrud E, Brix B, Hansson O. Towards a unified protocol for handling of CSF before \u03b2-amyloid measurements. Alzheimers Res Ther. 2019;11(1):63.","journal-title":"Alzheimers Res Ther"},{"key":"1571_CR28","doi-asserted-by":"crossref","unstructured":"Gobom J, Parnetti L, Rosa-Neto P, Vyhnalek M, Gauthier S, Cataldi S et al. Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid. 2022;60(2):207\u201319.","DOI":"10.1515\/cclm-2021-0651"},{"issue":"1","key":"1571_CR29","doi-asserted-by":"publisher","first-page":"6635","DOI":"10.1038\/s41467-022-34129-4","volume":"13","author":"A Pichet Binette","year":"2022","unstructured":"Pichet Binette A, Franzmeier N, Spotorno N, Ewers M, Brendel M, Biel D, et al. Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer\u2019s disease. Nat Commun. 2022;13(1):6635.","journal-title":"Nat Commun"},{"issue":"3","key":"1571_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res"},{"key":"1571_CR31","unstructured":"Lezak MD. Neuropsychological assessment. [Internet]. 5. ed. Oxford University Press; 2012. http:\/\/ludwig.lub.lu.se\/login?url=https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=cat07147a&AN=lub.4785165&site=eds-live&scope=site"},{"issue":"3","key":"1571_CR32","doi-asserted-by":"publisher","first-page":"P154","DOI":"10.1093\/geronj\/47.3.P154","volume":"47","author":"WJ Mack","year":"1992","unstructured":"Mack WJ, Freed DM, Williams BW, Henderson VW. Boston naming test: shortened versions for Use in Alzheimer\u2019s Disease. J Gerontol. 1992;47(3):P154\u20138.","journal-title":"J Gerontol"},{"issue":"3","key":"1571_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","volume":"8","author":"RM Reitan","year":"1958","unstructured":"Reitan RM. Validity of the trail making test as an Indicator of Organic Brain damage. Percept Mot Skills. 1958;8(3):271\u20136.","journal-title":"Percept Mot Skills"},{"key":"1571_CR34","doi-asserted-by":"crossref","unstructured":"Smith A. Symbol digit modalities test. Western psychological services Los Angeles; 1973.","DOI":"10.1037\/t27513-000"},{"key":"1571_CR35","volume-title":"The visual object and space perception battery","author":"EK Warrington","year":"1991","unstructured":"Warrington EK, James M, Thames Valley Test Company. The visual object and space perception battery. Bury St. Edmunds: Thames Valley Test Company Bury St. Edmunds; 1991."},{"key":"1571_CR36","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.nicl.2017.05.022","volume":"15","author":"D Berron","year":"2017","unstructured":"Berron D, Vieweg P, Hochkeppler A, Pluta JB, Ding SL, Maass A, et al. A protocol for manual segmentation of medial temporal lobe subregions in 7Tesla MRI. NeuroImage Clin. 2017;15:466\u201382.","journal-title":"NeuroImage Clin"},{"issue":"12","key":"1571_CR37","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1002\/hbm.24607","volume":"40","author":"L Xie","year":"2019","unstructured":"Xie L, Wisse LEM, Pluta J, de Flores R, Piskin V, Manj\u00f3n JV, et al. Automated segmentation of medial temporal lobe subregions on in vivo T1-weighted MRI in early stages of Alzheimer\u2019s disease. Hum Brain Mapp. 2019;40(12):3431\u201351.","journal-title":"Hum Brain Mapp"},{"key":"1571_CR38","doi-asserted-by":"publisher","first-page":"102683","DOI":"10.1016\/j.media.2022.102683","volume":"83","author":"L Xie","year":"2023","unstructured":"Xie L, Wisse LEM, Wang J, Ravikumar S, Khandelwal P, Glenn T, et al. Deep label fusion: a generalizable hybrid multi-atlas and deep convolutional neural network for medical image segmentation. Med Image Anal. 2023;83:102683.","journal-title":"Med Image Anal"},{"issue":"1","key":"1571_CR39","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/hbm.22627","volume":"36","author":"PA Yushkevich","year":"2015","unstructured":"Yushkevich PA, Pluta JB, Wang H, Xie L, Ding SL, Gertje EC, et al. Automated volumetry and regional thickness analysis of hippocampal subfields and medial temporal cortical structures in mild cognitive impairment. Hum Brain Mapp. 2015;36(1):258\u201387.","journal-title":"Hum Brain Mapp"},{"issue":"6","key":"1571_CR40","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/alz.12079","volume":"16","author":"R de Flores","year":"2020","unstructured":"de Flores R, Wisse LEM, Das SR, Xie L, McMillan CT, Trojanowski JQ, et al. Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer\u2019s disease. Alzheimers Dement. 2020;16(6):843\u201352.","journal-title":"Alzheimers Dement"},{"key":"1571_CR41","doi-asserted-by":"publisher","unstructured":"Touroutoglou A, Katsumi Y, Brickhouse M, Zaitsev A, Eckbo R, Aisen P et al. The Sporadic Early-onset Alzheimer\u2019s Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer\u2019s Disease Study (LEADS) Cohort. Alzheimers Dement [Internet]. 2023 Oct 18 [cited 2023 Nov 8];n\/a(n\/a). https:\/\/doi.org\/10.1002\/alz.13466","DOI":"10.1002\/alz.13466"},{"issue":"8","key":"1571_CR42","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1001\/jamaneurol.2020.0989","volume":"77","author":"A Leuzy","year":"2020","unstructured":"Leuzy A, Smith R, Ossenkoppele R, Santillo A, Borroni E, Klein G, et al. Diagnostic performance of RO948 F 18 Tau Positron Emission Tomography in the differentiation of Alzheimer Disease from Other Neurodegenerative disorders. JAMA Neurol. 2020;77(8):955\u201365.","journal-title":"JAMA Neurol"},{"key":"1571_CR43","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.dib.2017.10.024","volume":"15","author":"SL Baker","year":"2017","unstructured":"Baker SL, Maass A, Jagust WJ. Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data. Data Brief. 2017;15:648\u201357.","journal-title":"Data Brief"},{"issue":"5","key":"1571_CR44","first-page":"904","volume":"39","author":"OG Rousset","year":"1998","unstructured":"Rousset OG, Ma Y, Evans AC. Correction for partial volume effects in PET: principle and validation. J Nucl Med. 1998;39(5):904\u201311.","journal-title":"J Nucl Med"},{"issue":"2","key":"1571_CR45","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ana.24711","volume":"80","author":"H Cho","year":"2016","unstructured":"Cho H, Choi J, Hwang M, Kim Y, Lee H, Lee H, et al. In vivo cortical spreading pattern of tau and amyloid in the Alzheimer Disease Spectrum. Ann Neurol. 2016;80(2):247\u201358.","journal-title":"Ann Neurol"},{"issue":"2","key":"1571_CR46","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/jamaneurol.2021.4654","volume":"79","author":"A Leuzy","year":"2022","unstructured":"Leuzy A, Smith R, Cullen NC, Strandberg O, Vogel JW, Binette AP, et al. Biomarker-based prediction of longitudinal tau Positron Emission Tomography in Alzheimer Disease. JAMA Neurol. 2022;79(2):149\u201358.","journal-title":"JAMA Neurol"},{"key":"1571_CR47","doi-asserted-by":"publisher","first-page":"117471","DOI":"10.1016\/j.neuroimage.2020.117471","volume":"225","author":"S Cerri","year":"2021","unstructured":"Cerri S, Puonti O, Meier DS, Wuerfel J, M\u00fchlau M, Siebner HR, et al. A contrast-adaptive method for simultaneous whole-brain and lesion segmentation in multiple sclerosis. NeuroImage. 2021;225:117471.","journal-title":"NeuroImage"},{"key":"1571_CR48","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuroimage.2016.09.011","volume":"143","author":"O Puonti","year":"2016","unstructured":"Puonti O, Iglesias JE, Van Leemput K. Fast and sequence-adaptive whole-brain segmentation using parametric bayesian modeling. NeuroImage. 2016;143:235\u201349.","journal-title":"NeuroImage"},{"key":"1571_CR49","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2020","unstructured":"R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2020."},{"issue":"4","key":"1571_CR50","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/WNN.0000000000000245","volume":"33","author":"Y Chishiki","year":"2020","unstructured":"Chishiki Y, Hirano S, Li H, Kojima K, Nakano Y, Sakurai T, et al. Different patterns of Gray Matter volume reduction in early-onset and late-onset Alzheimer Disease. Cogn Behav Neurol off J Soc Behav Cogn Neurol. 2020;33(4):253\u20138.","journal-title":"Cogn Behav Neurol off J Soc Behav Cogn Neurol"},{"key":"1571_CR51","doi-asserted-by":"publisher","first-page":"563559","DOI":"10.3389\/fnagi.2020.563559","volume":"12","author":"EC Lee","year":"2020","unstructured":"Lee EC, Kang JM, Seo S, Seo HE, Lee SY, Park KH, et al. Association of Subcortical Structural shapes with tau, amyloid, and cortical atrophy in early-onset and late-onset Alzheimer\u2019s Disease. Front Aging Neurosci. 2020;12:563559.","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"1571_CR52","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1016\/j.neurobiolaging.2015.04.011","volume":"36","author":"R Ossenkoppele","year":"2015","unstructured":"Ossenkoppele R, Mattsson N, Teunissen CE, Barkhof F, Pijnenburg Y, Scheltens P, et al. Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer\u2019s Disease. Neurobiol Aging. 2015;36(8):2340\u20137.","journal-title":"Neurobiol Aging"},{"issue":"6","key":"1571_CR53","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s00259-021-05669-6","volume":"49","author":"D Visser","year":"2022","unstructured":"Visser D, Verfaillie SCJ, Wolters EE, Coomans EM, Timmers T, Tuncel H, et al. Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2022;49(6):1951\u201363.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"1571_CR54","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1093\/brain\/awaa327","volume":"143","author":"R Smith","year":"2020","unstructured":"Smith R, Strandberg O, Mattsson-Carlgren N, Leuzy A, Palmqvist S, Pontecorvo MJ, et al. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects. Brain. 2020;143(12):3805\u201315.","journal-title":"Brain"},{"issue":"12","key":"1571_CR55","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/acn3.51689","volume":"9","author":"A Tort-Merino","year":"2022","unstructured":"Tort-Merino A, Falg\u00e0s N, Allen IE, Balasa M, Olives J, Contador J, et al. Early-onset Alzheimer\u2019s disease shows a distinct neuropsychological profile and more aggressive trajectories of cognitive decline than late-onset. Ann Clin Transl Neurol. 2022;9(12):1962\u201373.","journal-title":"Ann Clin Transl Neurol"},{"key":"1571_CR56","unstructured":"Zhu XC, Tan L, Wang HF, Jiang T, Cao L, Wang C et al. Rate of early onset Alzheimer\u2019s disease: a systematic review and meta-analysis. Ann Transl Med Vol 3 No 3 March 10 2015 Ann Transl Med [Internet]. 2015 [cited 2015 Jan 1]; https:\/\/atm.amegroups.org\/article\/view\/5826"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01571-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01571-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01571-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T08:17:14Z","timestamp":1726647434000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01571-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1571"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01571-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.05.21.594976","asserted-by":"object"}]},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"16 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Regionala Etikspr\u00f6vningsn\u00e4mnden i Lund (regional ethical review board in Lund), Sweden, and all study participants provided written informed consent in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A.W., A.P.B., H.B., E.S., O.S., D.W., N.M.-C, N.S., P.A.Y., and L.E.M.W. have nothing to declare. D.B. is co-founder of neotiv GmbH. R.S. has received a speaker fee from Roche. S.P. has acquired research support (for the institution) from ki elements \/ ADDF and Avid. In the past 2 years, he has received consultancy\/speaker fees from Bioartic, Biogen, Esai, Lilly, and Roche. O.H. has acquired research support (for the institution) from AVID Radiopharmaceuticals, Biogen, C2N Diagnostics, Eli Lilly, Eisai, Fujirebio, GE Healthcare, and Roche. In the past 2 years, he has received consultancy\/speaker fees from AC Immune, Alzpath, BioArctic, Biogen, Bristol Meyer Squibb, Cerveau, Eisai, Eli Lilly, Fujirebio, Merck, Novartis, Novo Nordisk, Roche, Sanofi and Siemens.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}